* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.
* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.
* ÇöÀç ÄÁÅÙÃ÷ Á¤º¸¸¦ Áغñ Áß¿¡ ÀÖ½À´Ï´Ù.
¤ýMutation of individual protein C cleavage sites in Human coagulation factor Va
¤ý¼±Çü°¡¼Ó±âÀÇ QA¾÷¹«¿¡ °üÇÑ °íÂû
¤ýÇ÷û¿¡¼ ¾Ç¼ºÁ¾¾ç°Ë»ç¸¦ À§ÇÑ DR-70 EIA kitÀÇ À¯¿ë¼º
¤ýÆó¼â¼º ¼ö¸é ¹«È£ÈíÁõȯÀÚ¿¡¼ HLA-DQ B1 0602¿Í HLA-DQA1 0102 À¯ÀüÀÚÀÇ ¹ßÇö
¤ý¼ö¸é ¹«È£ÈíÁõ ȯÀÚ¿¡¼ Angiotensin converting enzyme, Angiotensinogen M235TÀÇ À¯ÀüÀû ´ÙÇü¼º
¤ýÄ¡±â°ø¿ë ±Ý¼ÓÀÇ °í°´ ¸¸Á·µµ Æò°¡¿¡ °üÇÑ ¿¬±¸ - ±Í±Ý¼Ó ÇÕ±ÝÀ» Áß½ÉÀ¸·Î
¤ýÀϺΠ´ëÁß ¸ñ¿åÅÁ ¿å¼öÀÇ ·¹Áö¿À³Ú¶ó±Õ ºÐÆ÷½ÇÅ ¹× Ç÷ûÇÐÀû Ư¼º
¤ýAntibacterial properties of silver ions released from the silver-impregnated activated carbons established on point-of-use (POU) home water purification devices
¤ý¸Þ¹Ðä¼Ò°¡·ç¸¦ ÷°¡ÇÑ ¸Þ¹Ð½Ä»§ÀÇ Ç°ÁúƯ¼º
¤ýÂý½Ò, ¸ã½Ò ¹× Èæ¹Ì ½ÄÇýÀÇ °ü´ÉÀû Ư¼º
¤ý¿ÁÇÔÀ¯ ÇÊÅÍÆÄÀÌÇÁÀÇ ´ã¹è ÁÖ¿ä À¯Çع°Áú Àú°¨È¿°ú
¤ýº¸°Ç°úÇבּ¸¼Ò ÇöȲ ¿Ü